The current and former Precinct 1 commissioners will host the 11th annual Prostate Cancer Education and Screening Event at Moncrief Cancer Institute.

A new study gives hope for improved treatment of prostate cancer, the second most diagnosed cancer among men worldwide.

The Melbourne-based nuclear medicine company is expected to be a major player in the US radiopharmaceutical market.

Imaging technology developed and refined at the University of Waterloo promises better detection and treatment of breast ...

Researchers explored how Pluvicto is used in the community and academic settings and when given by oncologists or urologists.

Accurate calculation of prostate-specific antigen doubling time can be crucial for prostate cancer treatment decisions but is ...

Imaging technology developed and refined at the University of Waterloo promises better detection and treatment of breast ...

I will be out for a period of time recovering -- hopefully quickly -- and when I get back, I plan to share my journey with ...

We all have a unique face, fingerprint, voice, and signature, so why wouldn’t we have a unique response to the medicine and ...

Celcuity's gedatolisib, a dual PI3K/mTOR inhibitor, shows promise in Phase 3 breast cancer trials. Click here to read an ...

Immune therapy has transformed how cancer is treated, but many tumors continue to evade these treatments, thanks to their ...